Pharos Capital Partners
Pharos Capital Group is a physician-founded private equity firm focused on growing healthcare companies.
Business Model: B2B
Revenue: $18.6M
Employees: 11-50
Rankings
Industries / Tags:
Detailed Pharos Capital Partners Information
Geographic Data
Address: 3889 Maple Avenue
City: Dallas
State: TX
Zip: 75219
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$202M
Social
Facebook
Twitter
Linkedin
Crunchbase
Metrics
4,818,938Website Global Rank
1,781Website Monthly Traffic
Twitter Followers
Description
Based in Dallas and Nashville, Pharos Capital Group (“Pharosâ€) has $600 million in capital under management through three private equity funds. Their latest partnership is a $400 million fund focused on providing later stage equity funding for internal growth, acquisitions, leveraged buyouts, management buyouts or recapitalizations across industry sectors, with particular focus on healthcare, business services and technology. Pharos typically takes $10 to $30 million equity positions through staged investing in undercapitalized businesses in underserved regions across the nation. They typically are the lead investor in a round, or will co-lead a financing along with other institutional investors. Their investment mandate is to be value added investors who bring more than just capital to the table.
Contact Phone:
+12148550194
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 1/2014 | Motion PT | Private Equity Round | - |
| 7/2006 | VeriCenter | Venture Round | 7M |
| 9/2022 | Renal Care 360 | Private Equity Round | - |
| 4/2002 | Atherotech Diagnostics Lab | Private Equity Round | 0 |
| 1/2015 | Sona Dermatology &a; MedSpa | Private Equity Round | - |
| 5/2006 | Aurora Imaging Technology | Series C | 10M |
| 3/2008 | Handango | Series C | 0 |
| 11/2008 | Alereon | Venture Round | 0 |
| 1/2018 | Verdi Oncology | Private Equity Round | - |
| 5/2022 | Sanderling | Private Equity Round | - |
| 1/2004 | Alereon | Series A | 31.5M |
| 9/2006 | Handango | Series B | 60.5M |
| 1/2006 | Windsor Health Group | Series A | 9M |
| 12/2004 | Travel Holdings | Venture Round | 0 |
| 9/2007 | Alereon | Series B | 18.5M |
| 10/2005 | Alereon | Series B | 20M |
| 8/2006 | Egenera | Series E | 26M |
| 5/2016 | Beacon Specialized Living Services | Private Equity Round | - |
| 12/2006 | Pioneer Surgical | Private Equity Round | 0 |
| 1/2016 | Family Treatment Network | Private Equity Round | - |
| 1/2013 | Seaside Healthcare | Private Equity Round | - |
| 1/2006 | MCCI Medical Group | Private Equity Round | - |
| 6/2012 | Alereon | Unattributed | 6M |
| 5/2022 | Sanderling | Private Equity Round | - |
| 1/2018 | Verdi Oncology | Private Equity Round | - |
| 5/2016 | Beacon Specialized Living Services | Private Equity Round | - |
| 1/2016 | Family Treatment Network | Private Equity Round | - |
| 1/2015 | Sona Dermatology &a; MedSpa | Private Equity Round | - |
| 1/2014 | Motion PT | Private Equity Round | - |
| 1/2013 | Seaside Healthcare | Private Equity Round | - |
| 6/2012 | Alereon | Venture Round | 0 |
| 11/2008 | Alereon | Venture Round | 0 |
| 3/2008 | Handango | Series C | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
